FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3125948343> ?p ?o ?g. }

• W3125948343 abstract "Abstract Background Access and adherence to artemisinin-based combination therapy (ACT) are key challenges to effective malaria treatment. A secondary analysis of the Sierra Leone malaria Knowledge, Attitudes, and Practices (mKAP) survey was conducted to investigate access and adherence to ACT for the treatment of fever in children under-five. Methods The mKAP was a nationally representative, two-stage cluster-sample survey, conducted in 2012. Thirty primary sampling units per district were randomly selected using probability proportionate to size, based on national census estimates; 14 households were subsequently randomly selected and enrolled per sampling unit. The analysis was restricted to children under-five with fever in the past two weeks. Factors associated with access and adherence were assessed using multivariate logistic regression. Results Of 5169 enrolled households, 1456 reported at least one child under-five with fever in the past two weeks. Of the 1641 children from these households, 982 (59.8%) received any treatment for fever and were analysed for access to ACT; 469 (47.6%) received ACT and 466 were analysed for treatment adherence. Only 222 (47.4%) febrile children received ACT and completed 3-day treatment. In an adjusted analysis, factors associated with ACT access included knowledge of ACT (odds ratio [OR] 2.78, 95% CI 2.02–3.80; p < 0.001), knowledge of insecticide-treated nets (ITNs) (OR 1.84, 95% CI 1.29–2.63; p = 0.001), source of care (public health facility vs. other; OR 1.86, 95% CI 1.27–2.72, p = 0.001), geographic region (East vs. West; OR 2.30, 95% CI 1.20–4.44; p = 0.025), and age (24–59 vs. 0–23 months; OR 1.45, 95% CI 1.07–1.96; p = 0.016). The only factor associated with ACT adherence was time to treatment; children treated within 24 h were less likely to adhere (OR 0.55, 95% CI 0.34–0.89; p = 0.015). Conclusions In 2012, access and adherence to ACT remained low in Sierra Leone. Knowledge of ACT and ITNs, and seeking care in the public sector, were most strongly associated with ACT access. National surveys provide important information on anti-malarial access and could be expanded to measure treatment adherence." @default.
• W3125948343 created "2021-02-01" @default.
• W3125948343 creator A5016082976 @default.
• W3125948343 creator A5020242502 @default.
• W3125948343 creator A5026726987 @default.
• W3125948343 creator A5029384863 @default.
• W3125948343 creator A5032201964 @default.
• W3125948343 creator A5032840523 @default.
• W3125948343 date "2021-01-21" @default.
• W3125948343 modified "2023-10-15" @default.
• W3125948343 title "Factors associated with access and adherence to artemisinin‐based combination therapy (ACT) for children under five: a secondary analysis of a national survey in Sierra Leone" @default.
• W3125948343 cites W1806888623 @default.
• W3125948343 cites W1971919551 @default.
• W3125948343 cites W1985810025 @default.
• W3125948343 cites W1986016492 @default.
• W3125948343 cites W2000745612 @default.
• W3125948343 cites W2004177351 @default.
• W3125948343 cites W2019668483 @default.
• W3125948343 cites W2050622314 @default.
• W3125948343 cites W2084977582 @default.
• W3125948343 cites W2100970784 @default.
• W3125948343 cites W2110470830 @default.
• W3125948343 cites W2115678100 @default.
• W3125948343 cites W2129695802 @default.
• W3125948343 cites W2134041710 @default.
• W3125948343 cites W2138107286 @default.
• W3125948343 cites W2145166645 @default.
• W3125948343 cites W2153584506 @default.
• W3125948343 cites W2162391545 @default.
• W3125948343 cites W2164108601 @default.
• W3125948343 cites W2737189329 @default.
• W3125948343 cites W2739329641 @default.
• W3125948343 cites W2783247289 @default.
• W3125948343 cites W2906688916 @default.
• W3125948343 cites W2971580763 @default.
• W3125948343 cites W4237146277 @default.
• W3125948343 doi "https://doi.org/10.1186/s12936-021-03590-9" @default.
• W3125948343 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7817959" @default.
• W3125948343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33478507" @default.
• W3125948343 hasPublicationYear "2021" @default.
• W3125948343 type Work @default.
• W3125948343 sameAs 3125948343 @default.
• W3125948343 citedByCount "5" @default.
• W3125948343 countsByYear W31259483432021 @default.
• W3125948343 countsByYear W31259483432022 @default.
• W3125948343 countsByYear W31259483432023 @default.
• W3125948343 crossrefType "journal-article" @default.
• W3125948343 hasAuthorship W3125948343A5016082976 @default.
• W3125948343 hasAuthorship W3125948343A5020242502 @default.
• W3125948343 hasAuthorship W3125948343A5026726987 @default.
• W3125948343 hasAuthorship W3125948343A5029384863 @default.
• W3125948343 hasAuthorship W3125948343A5032201964 @default.
• W3125948343 hasAuthorship W3125948343A5032840523 @default.
• W3125948343 hasBestOaLocation W31259483431 @default.
• W3125948343 hasConcept C126322002 @default.
• W3125948343 hasConcept C138816342 @default.
• W3125948343 hasConcept C144024400 @default.
• W3125948343 hasConcept C149923435 @default.
• W3125948343 hasConcept C151956035 @default.
• W3125948343 hasConcept C156957248 @default.
• W3125948343 hasConcept C159110408 @default.
• W3125948343 hasConcept C164866538 @default.
• W3125948343 hasConcept C187212893 @default.
• W3125948343 hasConcept C199360897 @default.
• W3125948343 hasConcept C203014093 @default.
• W3125948343 hasConcept C2776120307 @default.
• W3125948343 hasConcept C2778048844 @default.
• W3125948343 hasConcept C2778371730 @default.
• W3125948343 hasConcept C3018567284 @default.
• W3125948343 hasConcept C38180746 @default.
• W3125948343 hasConcept C41008148 @default.
• W3125948343 hasConcept C45355965 @default.
• W3125948343 hasConcept C512399662 @default.
• W3125948343 hasConcept C71924100 @default.
• W3125948343 hasConcept C99454951 @default.
• W3125948343 hasConceptScore W3125948343C126322002 @default.
• W3125948343 hasConceptScore W3125948343C138816342 @default.
• W3125948343 hasConceptScore W3125948343C144024400 @default.
• W3125948343 hasConceptScore W3125948343C149923435 @default.
• W3125948343 hasConceptScore W3125948343C151956035 @default.
• W3125948343 hasConceptScore W3125948343C156957248 @default.
• W3125948343 hasConceptScore W3125948343C159110408 @default.
• W3125948343 hasConceptScore W3125948343C164866538 @default.
• W3125948343 hasConceptScore W3125948343C187212893 @default.
• W3125948343 hasConceptScore W3125948343C199360897 @default.
• W3125948343 hasConceptScore W3125948343C203014093 @default.
• W3125948343 hasConceptScore W3125948343C2776120307 @default.
• W3125948343 hasConceptScore W3125948343C2778048844 @default.
• W3125948343 hasConceptScore W3125948343C2778371730 @default.
• W3125948343 hasConceptScore W3125948343C3018567284 @default.
• W3125948343 hasConceptScore W3125948343C38180746 @default.
• W3125948343 hasConceptScore W3125948343C41008148 @default.
• W3125948343 hasConceptScore W3125948343C45355965 @default.
• W3125948343 hasConceptScore W3125948343C512399662 @default.
• W3125948343 hasConceptScore W3125948343C71924100 @default.
• W3125948343 hasConceptScore W3125948343C99454951 @default.
• W3125948343 hasFunder F4320307851 @default.
• W3125948343 hasFunder F4320308335 @default.
• W3125948343 hasFunder F4320337356 @default.
• W3125948343 hasIssue "1" @default.

• next